Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
0.9998
+0.0900 (9.89%)
At close: Dec 19, 2025, 4:00 PM EST
1.000
+0.000 (0.02%)
After-hours: Dec 19, 2025, 6:26 PM EST
Dyadic International Market Cap
Dyadic International has a market cap or net worth of $36.18 million as of December 19, 2025. Its market cap has decreased by -25.40% in one year.
Market Cap
36.18M
Enterprise Value
32.31M
1-Year Change
-25.40%
Ranking
Category
Stock Price
$1.00
Market Cap Chart
Since April 18, 2019, Dyadic International's market cap has decreased from $94.80M to $36.18M, a decrease of -61.83%. That is a compound annual growth rate of -13.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 36.20M | -30.12% |
| Dec 31, 2024 | 51.80M | 11.64% |
| Dec 29, 2023 | 46.40M | 32.19% |
| Dec 30, 2022 | 35.10M | -72.34% |
| Dec 31, 2021 | 126.90M | -14.20% |
| Dec 31, 2020 | 147.90M | 4.89% |
| Dec 31, 2019 | 141.00M | 48.73% |
| Apr 18, 2019 | 94.80M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.80B |
| Johnson & Johnson | 506.75B |
| AbbVie | 396.44B |
| UnitedHealth Group | 300.40B |
| AstraZeneca | 281.50B |
| Novartis AG | 260.63B |
| Merck & Co. | 246.17B |
| Abbott Laboratories | 220.33B |